The U.S. Food and Drug Administration now requires that all oral and rectal nonprescription aspirin and aspirin-containing drug products include a label warning against use by women in the last three months of pregnancy, unless otherwise directed by a physician.

The warning must be included on aspirin products manufactured after Aug. 5, 1990. The warning reads:

This content is only available via PDF.
You do not currently have access to this content.